Global Dermatology Drug Competitive Landscape Professional Research Report 2025
Research Summary
A dermatology drug is a pharmaceutical substance specifically formulated to treat various skin conditions and disorders, ranging from common skin ailments like acne, eczema, and psoriasis to more severe conditions such as skin cancer. These drugs can be administered topically as creams, ointments, or lotions, or in some cases, taken orally or through injections. Dermatology drugs work by targeting specific pathways, cells, or mechanisms involved in the development of skin disorders, aiming to alleviate symptoms, reduce inflammation, regulate immune responses, or inhibit abnormal cell growth. These drugs play a crucial role in managing skin health, promoting healing, and enhancing the quality of life for individuals dealing with dermatological issues.
According to DIResearch's in-depth investigation and research, the global Dermatology Drug market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Dermatology Drug include AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Valeant, Merz Pharma, GlaxoSmithKline, LEO Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Dermatology Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Dermatology Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Dermatology Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Dermatology Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Dermatology Drug Include:
AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Valeant
Merz Pharma
GlaxoSmithKline
LEO Pharma
Dermatology Drug Product Segment Include:
External Drug
Oral Drug
Injection Solution
Dermatology Drug Product Application Include:
Psoriasis
Skin Infections
Acne
Dermatitis
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Dermatology Drug Industry PESTEL Analysis
Chapter 3: Global Dermatology Drug Industry Porter’s Five Forces Analysis
Chapter 4: Global Dermatology Drug Major Regional Market Size and Forecast Analysis
Chapter 5: Global Dermatology Drug Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Dermatology Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Dermatology Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Dermatology Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Dermatology Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Dermatology Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Dermatology Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Dermatology Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Dermatology Drug Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Dermatology Drug Product by Type
- 1.2.1 External Drug
- 1.2.2 Oral Drug
- 1.2.3 Injection Solution
- 1.3 Dermatology Drug Product by Application
- 1.3.1 Psoriasis
- 1.3.2 Skin Infections
- 1.3.3 Acne
- 1.3.4 Dermatitis
- 1.3.5 Others
- 1.4 Global Dermatology Drug Market Size Analysis (2020-2032)
- 1.5 Dermatology Drug Market Development Status and Trends
- 1.5.1 Dermatology Drug Industry Development Status Analysis
- 1.5.2 Dermatology Drug Industry Development Trends Analysis
- 2 Dermatology Drug Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Dermatology Drug Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Dermatology Drug Market Analysis by Regions
- 4.1 Dermatology Drug Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Dermatology Drug Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Dermatology Drug Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Dermatology Drug Revenue Forecast by Region (2026-2032)
- 5 Global Dermatology Drug Market Size by Type and Application
- 5.1 Global Dermatology Drug Market Size by Type (2020-2032)
- 5.2 Global Dermatology Drug Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Dermatology Drug Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Dermatology Drug Market Size by Type
- 6.4 North America Dermatology Drug Market Size by Application
- 6.5 North America Dermatology Drug Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Dermatology Drug Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Dermatology Drug Market Size by Type
- 7.4 Europe Dermatology Drug Market Size by Application
- 7.5 Europe Dermatology Drug Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Dermatology Drug Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Dermatology Drug Market Size by Type
- 8.4 China Dermatology Drug Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Dermatology Drug Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Dermatology Drug Market Size by Type
- 9.4 APAC (excl. China) Dermatology Drug Market Size by Application
- 9.5 APAC (excl. China) Dermatology Drug Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Dermatology Drug Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Dermatology Drug Market Size by Type
- 10.4 Latin America Dermatology Drug Market Size by Application
- 10.5 Latin America Dermatology Drug Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Dermatology Drug Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Dermatology Drug Market Size by Type
- 11.4 Middle East & Africa Dermatology Drug Market Size by Application
- 11.5 Middle East & Africa Dermatology Drug Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Dermatology Drug Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Dermatology Drug Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Dermatology Drug Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 AbbVie
- 13.1.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 AbbVie Dermatology Drug Product Portfolio
- 13.1.3 AbbVie Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Johnson & Johnson
- 13.2.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Johnson & Johnson Dermatology Drug Product Portfolio
- 13.2.3 Johnson & Johnson Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Bayer
- 13.3.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Bayer Dermatology Drug Product Portfolio
- 13.3.3 Bayer Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Galderma
- 13.4.1 Galderma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Galderma Dermatology Drug Product Portfolio
- 13.4.3 Galderma Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Bristol-Myers Squibb
- 13.5.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Bristol-Myers Squibb Dermatology Drug Product Portfolio
- 13.5.3 Bristol-Myers Squibb Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Novartis
- 13.6.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Novartis Dermatology Drug Product Portfolio
- 13.6.3 Novartis Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Pfizer
- 13.7.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Pfizer Dermatology Drug Product Portfolio
- 13.7.3 Pfizer Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Valeant
- 13.8.1 Valeant Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Valeant Dermatology Drug Product Portfolio
- 13.8.3 Valeant Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Merz Pharma
- 13.9.1 Merz Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Merz Pharma Dermatology Drug Product Portfolio
- 13.9.3 Merz Pharma Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 GlaxoSmithKline
- 13.10.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 GlaxoSmithKline Dermatology Drug Product Portfolio
- 13.10.3 GlaxoSmithKline Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 LEO Pharma
- 13.11.1 LEO Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 LEO Pharma Dermatology Drug Product Portfolio
- 13.11.3 LEO Pharma Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Dermatology Drug Industry Chain Analysis
- 14.2 Dermatology Drug Industry Raw Material and Suppliers Analysis
- 14.2.1 Dermatology Drug Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Dermatology Drug Typical Downstream Customers
- 14.4 Dermatology Drug Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook